UCB SA

OTC
UCBJF
Stock
Yield per half year: +1%
Dividend yield: 0.9607%
Sector: Healthcare

UCB SA

220.00220.00200.00200.00180.00180.00160.00160.00140.00140.00120.00120.00Aug '24Aug '24Sep '24Sep '24Oct '24Oct '24Nov '24Nov '24Dec '24Dec '2420252025Feb '25Feb '25Mar '25Mar '25Apr '25Apr '25May '25May '25Jun '25Jun '25

Underestimation

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
P/E
5/10
35.99 54.24 -33.64% 31.9 +12.82%
P/S 6.23 4.62 34.85%
P/BV 3.67 4.2 -12.48%
P/FCF 18.15 16.2 12.07%
Ev/Ebitda 20.3 14.71 38.02%
Ev/S 6.48 4.05 59.85%
Ev/FCF 41.62 20.97 98.43%
E/P 0.0613 1.63 -96.23%

Efficiency

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Ebitda margin
9/10
31.91 25.2 26.62% 27.39 +16.5%
ROE 10.97 12.46 -11.96%
ROA 6.34 6.23 1.76%
ROIC 0 15.34 -100%
ROS 17.31 12.71 36.2%
ROCE 12.67 14.68 -13.7%

Debt

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Debt/Ebitda
7/10
1.6 6.22 -74.2% 1.84 -12.83%
Nеt Debt/Ebitda 0.7702 -3.47 -122.17%
Debt/Ratio 0.1744 0.2246 -22.34%
Debt/Equity 0.7297 1 -27.14%
Debt/Net Income 2.96 18.36 -83.9%

Dividends

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Dividend yield
2.4/10
0.9607 2.28 -57.88% 1.21 -20.34%
Number of years of dividend growth 2 1.59 25.66%
DSI 0.8571 0.7935 8.02%
Average dividend growth -1811 -303.64 496.44%
Average percentage for 5 years 1.21 2.59 -53.48%
Average percentage for payments 74.03 167.32 -55.76%
Difference from average difference in sector -1.32

Growth impulse

Parameter Grade Value Sector average Difference with sector, %
Growth impulse Revenue in 5 years
4/10
27.11 -98.5 -127.52%
Growth impulse Ebitda in 5 years 66.36 -98.62 -167.29%
Growth impulse Net Income in 5 years 60.68 -98.32 -161.72%
Growth impulse FCF in 5 years 44.63 -98.32 -145.39%
Growth impulse EPS in 5 years 55.96 -82.03 -168.22%
IP Score
5.63/10

Similar companies

Astellas Pharma Inc.

Roche Holding

Sinopharm Group Co., Ltd.

Sinopharm Group Co., Ltd.

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription